FDA Reopens Comment Period for Gluten Free
The agency is overdue to finalize its gluten-free labeling rule since issuing the proposed rule in 2007.
Beginning August 3, FDA has reopened the comment period for its proposed gluten-free food-labeling rule. The comment period will remain open for 60 days.
The agency is overdue to finalize its gluten-free labeling rule since issuing the proposed rule in 2007. The agency has faced continued pressure to set standards that would establish the maximum gluten threshold for products labeled “gluten-free.”
Thus far, FDA has proposed that gluten-free foods cannot contain more than 20 parts per million (ppm) of gluten. It notes that this standard takes into account current technologies for detecting gluten in food and that “validated methods could not reliably detect the amount of gluten in a food when the level was less than 20 ppm.” Notably, the 20 ppm-standard matches those set by the Codex Alimentarius and by 27 countries in the EU.
Gluten is a protein found in wheat, rye, and barley. Those intolerant to gluten include celiac disease sufferers, which are estimate to include 1% of the U.S. population.
Read FDA’s offical statement here.
Read past Nutritional Outlook coverage on gluten-free labeling: http://www.nutritionaloutlook.com/article/gluten-free-guidancehttp://www.nutritionaloutlook.com/article/increasingly-gluten-free http://www.nutritionaloutlook.com/article/fda-considers-official-definition-gluten-free-foods
http://www.nutritionaloutlook.com/news/fast-growth-gluten-free-says-packaged-facts
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
